Molina Healthcare, Inc. – Consensus ‘buy’ rating and 11.4% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Molina Healthcare, Inc. which can be found using ticker (MOH) now have 16 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between 403 and 290 and has a mean target at $350.13. Now with the previous closing price of $314.23 and the analysts are correct then we can expect a percentage increase in value of 11.4%. The day 50 moving average is $301.17 and the 200 day MA is $299.93. The market capitalization for the company is 18.66B. The stock price for the company is currently is currently 320 USD

The potential market cap would be $20,787,401,839 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 19.93, revenue per share of 552.21 and a 7.4% return on assets.

Molina Healthcare, Inc. is a provider of managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces. The Company operates through four segments: Medicaid, Medicare, Marketplace, and Other. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which the Company offers managed healthcare services. Medicaid provides healthcare and long-term care services and support to low-income Americans. Medicare is a federal program that provides eligible persons aged 65 and over and some disabled persons with a variety of hospital, medical insurance, and prescription drug benefits. Marketplace insurance exchanges allow individuals and small groups to purchase federally subsidized health insurance. The Company arranges healthcare services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, and ancillary providers.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search